Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Feb 15, 2017 (10 years ago)

Ropivacaine HCl 0.2% 500 mL Total Volume in an ON-Q Pump in 0.9%…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Ropivacaine HCl 0.2% 500 mL Total Volume in an ON-Q Pump in 0.9% Sodium Chloride Injection in 400 mL, Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478, NDC: 61553-258-25

Affected NDC 61553-0258-25

Compare with the code on your package — it is the most precise check available.

Drug: Ropivacaine

Recalling firm
Pharmedium Services Llc
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0932-2017 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Ropivacaine recalls

See all
Class II · Moderate risk

Fentanyl citrate

CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.

Ongoing cGMP deviation Park Avenue Compounding NDC 83863-4272-1 D-0178-2026

Other recalls by Pharmedium Services Llc

All 2017 recalls